Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/32988
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: Dealing with doping. A plea for better science, governance and education
Author(s): Heuberger, Jules A A C
Henning, April
Cohen, Adam F
Kayser, Bengt
Contact Email: april.henning@stir.ac.uk
Keywords: Doping
Evidence-based Medicine
Clinical Pharmacology
General medicine
Public Health
Issue Date: 22-Jul-2021
Date Deposited: 27-Jul-2021
Citation: Heuberger JAAC, Henning A, Cohen AF & Kayser B (2021) Dealing with doping. A plea for better science, governance and education. British Journal of Clinical Pharmacology, 88 (2), pp. 566-578. https://doi.org/10.1111/bcp.14998
Abstract: First paragraph: A participant from the ancient Greek Olympics stepping into Tokyo's Olympic Stadium at the opening of the Games on 23 July 2021 would find the pageantry and competition familiar. Since doping-like behavior was prevalent at the time, the athlete would be confused by the efforts to detect the use of substances in the body fluids of his fellow athletes. The anti-doping lab at the 2016 Summer Games in Rio de Janeiro operated on a 24-hour basis, requiring 5'500m2 of space for its 30 mass spectrometry instruments and 700 staff. Tokyo's organizers have announced an even more elaborate operation. Current anti-doping efforts are extensive, expensive, and complex. They not only concern the Olympic Games but competitive sport in general, also targeting non-Olympic athletes and, increasingly, amateurs.
DOI Link: 10.1111/bcp.14998
Rights: This item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study. This is the peer reviewed version of the following article: Heuberger, JAAC, Henning, A, Cohen, AF, Kayser, B. Dealing with doping. A plea for better science, governance and education. Br J Clin Pharmacol. 2022; 88(2): 566-578., which has been published in final form at https://doi.org/10.1111/bcp.14998.This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
Licence URL(s): http://creativecommons.org/licenses/by-nc-nd/4.0/

Files in This Item:
File Description SizeFormat 
bcp.14998.pdfFulltext - Accepted Version1.11 MBAdobe PDFView/Open



This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.